Two cases of prostate cancer with disseminated carcinomatosis of the bone marrow treated with novel hormonal agents
Introduction Disseminated carcinomatosis of the bone marrow in prostate cancer is rare and has a poor prognosis. Although strong evidence suggests that novel hormonal agents improve the prognosis of metastatic prostate cancer, their effectiveness in cases of disseminated carcinomatosis of the bone m...
Main Authors: | Keina Nozaki, Hisashi Matsushima, Hiyo Obikane, Ryohei Nishimoto, Ryo Tanaka, Takeru Morishige, Tomoko Masuda, Haruki Kume |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-11-01
|
Series: | IJU Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/iju5.12611 |
Similar Items
-
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model
by: Mari I. Suominen, et al.
Published: (2023-08-01) -
Feasibility study of radium-223 production in Tehran Research Reactor for treatment of bone metastases
by: Reza Bagheri, et al.
Published: (2016-02-01) -
Marrow stromal cell culture /
by: Beresford, Jon N., et al.
Published: (1998) -
Bone marrow edema in terms of joint pathology
by: G. A. Airapetov, et al.
Published: (2020-11-01) -
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results
by: Matthew Winter, et al.
Published: (2022-08-01)